Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis

Digestive Diseases and Sciences

Volumn 42, Issue 11, 1997, Pages 2356-2366

  Stadnicki, Antoni ^b   Gonciarz, Maciej ^b   Niewiarowski, Tomasz J ^b   Hartleb, Jacek ^b   Rudnicki, Marek ^b   Merrell, Nancy B ^b   Dela Cadena, Raul A ^b   Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Coagulation; Kallikrein kinin system; Neutrophil activation; Ulcerative colitis

Indexed keywords

BETA THROMBOGLOBULIN; ELASTASE; KALLIKREIN; KININOGEN; PREKALLIKREIN; PROTHROMBIN; TRYPSIN INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING; CELL ACTIVATION; CLINICAL FEATURE; DISEASE ASSOCIATION; ENTEROCOLITIS; FEMALE; HUMAN; IMMUNE SYSTEM; KALLIKREIN KININ SYSTEM; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; ULCERATIVE COLITIS;

ADULT; BETA-THROMBOGLOBULIN; BLOOD COAGULATION; BLOTTING, WESTERN; COLITIS, ULCERATIVE; FEMALE; FIBRINOLYSIS; HUMANS; KALLIKREIN-KININ SYSTEM; MALE; NEUTROPHIL ACTIVATION; PLATELET ACTIVATION; PREKALLIKREIN;

EID: 0031438362     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018891323205     Document Type: Article

References (58)

1. Sartor RB: Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 24:475-508, 1995
2. Hudson M, Wakefield AJ, Hutton RA, Sankey EA, Dhillon AP, More L, Sim R, Pounder RE: Factor XIIIA subunit and Crohn's disease. Gut 34:75-79, 1993
3. Stadnicki A, Kloczko J, Nowak A, Sierka E, Sliwinski Z: Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis. Am J Gastroenterol 86:690-693, 1991
4. Wakefield A, Sawyerr A, Dhillon A, Pittilo R, Rowles P, Lewis A, Pounder R: Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 2:10157-1062, 1989
5. Webberley MJ, Hart MT, Melikian V: Thromboembolism in inflammatory bowel disease: Role of platelets. Gut 34:247-251, 1993
6. Collins CE, Cahill MR, Newland AC, Rampton DS: Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 106:840-845, 1994
7. Talbot RW, Heppell J, Dozois RR, Beart RW Jr: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140-145, 1986
8. Nemerson Y: Tissue factor and hemostasis. Blood 71:1-8, 1988
9. Hauert J, Bachmann F: Prourokinase activation in euglobulin fractions. Thromb Haemost 54:122-127, 1985
10. Wachtfogel YT, Kucich U, James HL, Scott CF, Schapira M, Zimmerman M, Cohen AB, Colman RW: Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 72:1672-1677, 1983
11. DeLa Cadena RA, Wachtfogel YT, Colman RW: Contact activation pathway: Inflammation and coagulation. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice. RW Colman, J Hirsh, VJ Marder, EW Salzman (eds). Philadelphia, JB Lippincott, 1994, p 219
12. Wuillemin WH, Minnema M, Meijers JC, Roem D, Eerenberg AJ, Nuijens JH, ten Cate H, Hack E: Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: Major role for C1 inhibitor. Blood 85:1517-1526, 1995
13. Zeitlin IJ, Smith AN: Mobilization of tissue kallikrein in inflammatory disease of the colon. Gut 14:133-138, 1973
14. Kotschy M, Lubczynska-Kowalska W, Sajewicz Z, Sekowska E: Coagulative, fibrinolytic and esterase activity in the plasma of patients with ulcerative colitis. Pol Tyg Lek 36:705-707, 1981 (in Polish)
15. Stadnicki A, DeLa Cadena RA, Sartor RB, Bender D, Kettner CA, Rath HC, Adam A, Colman RW: Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat. Dig Dis Sci 41:912-920, 1996
16. Talstad I, Gjone E: The disease activity of ulcerative colitis and Crohn's disease. Scand J Gastroenterol 11:403-408, 1976
17. Baron JH, Connell AM, Lennard-Jones JE: Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1:89-92, 1964
18. DeLa Cadena RA, Scott CF, Colman RW: Evaluation of a microassay for human plasma prekallikrein. J Lab Clin Med 109:601-607, 1987
19. Scott CF, Colman RW: A simple and accurate microplate assay for the determination of factor XI in plasma. J Lab Clin Med 111:708-714, 1988
20. Proctor RR, Rapaport SI: The partial thromboplastin time with kaolin: A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 36:212-219, 1961
21. Schapira M, Silver LD, Scott CF, Colman RW: New and rapid functional assay for C1 inhibitor in human plasma. Blood 59:719-724, 1982
22. Hock J, Vogel R, Linke RP, Muller Esterl W: High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. J Biol Chem 265:12005-12011, 1990
23. Page JD, Colman RW: Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371). J Biol Chem 266:8143-8148, 1991
24. 4. Nature 227:680-685, 1970
25. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 70:343-350, 1987
26. Francis CW, Alkjaersig N, Galanakis DK, Graeff H, Owen J, Gaffney P, Marder VJ: Terminology for macromolecular plasmic derivatives of crosslinked fibrin. Thromb Haemost 57:110-111, 1987
27. Rucinski B, Niewiarowski S, James P, Walz DA, Budzynski AZ: Anti-heparin proteins secreted by platelets: Purification, characterization and radioimmunoassay. Blood 53:47-40, 1979
28. Murphy EA: Biostatistics in Medicine. Baltimore, The Johns Hopkins Press, 1982
29. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine [see comments]. Chest 101:1644-1655, 1992
30. Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW: Activation of the contact system of plasma proteolvsis in the adult respiratory distress syndrome. J Lab Clin Med 112:270-277, 1988
31. Pixley RA, DeLa Cadena RA, Page JD, Kaufman N, Wyshock EG, Chang A, Taylor FB Jr, Colman RW: The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest 91:61-68, 1993
32. Colman RW, Edelman R, Scott CF, Gilman RH: Plasma kallikrein activation and inhibition during typhoid fever. J Clin Invest 61:287-296, 1978
33. DeLa Cadena RA, Suffredini AF, Page JD, Pixley RA, Kaufman N, Parrillo JE, Colman RW: Activation of the kailikrein-kinin system after endotoxin administration to normal human volunteers. Blood 81:3313-3317, 1993
34. Aasen AO, Ruud TE, Kaaresen R, Stadaas JO: Evaluation of patients with acute pancreatitis by means of chromogenic peptide substrate assays and the proenzyme functional inhibition index. Scand J Gastroenterol Suppl 126:40-45, 1986
35. Tanaka M, Suzuki A: Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers. Thromb Res 76:289-298, 1994
36. Stadnicki A, Sartor RB, Colman RW: Activation of the kallikrein-kinin system in indomethacin-induced enterocolitis in genetically susceptible rats. J Invest Med 44:299, 1996 (abstract)
37. Rao AK, Schapira M, Clements ML, Niewiarowski S, Budzynski AZ, Schmaier AH, Harpel PC, Blackwelder WC, Scherrer JR, Sobel E: A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. N Engl J Med 318:1021-1028, 1988
38. Roeise O, Sivertsen S, Ruud TE, Bouma BN, Stadaas JO, Aasen AO: Studies on components of the contact phase system in patients with advanced gastrointestinal cancer. Cancer 65:1355-1359, 1990
39. Scott CF, Silver LD, Schapira M, Colman RW: Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. J Clin Invest 73:954-462, 1984
40. Nuijens JH, Huijbregts CCM, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felts-Bersma RJ, Thijs LE, Hack CE: Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhihitor complexes in sepsis. Blood 72:1841-1848, 1988
41. Oshitani N, Kitano A, Nakamura S, Ohata A, Hashimura H, Hiki M, Okawa K, Kobayashi K: Dissociation between the functional activity and immunoreactive concentration of C1 esterase inhibitor in active and quiescent Crohn's disease. Scand J Gastroenterol 23:973-976, 1988
42. Schremmer J, Blank M, Wykle R: Bradykinin-stimulated release of arachidonic acid from phospholipids of HSDM1C1 cells: Comparison of diacyl phospholipids and plasmalogens as. Prostaglandins 18:491-505, 1979
43. Burch RM, Connor JR, Tiffany CW: The kallikrein-kininogen-kinin system in chronic inflammation. Agents Actions 27:258-260, 1989
44. Cuthbert AW, Margolius HS: Kinins stimulate net chloride secretion by the rat colon. Br J Pharmacol 75:587-598, 1982
45. Machovich R, Owen W: The elastase-mediated pathway of fibrinolysis. Blood Coag Fibrinolysis 1:79-90, 1990
46. Nuijens JH, Abbink JJ, Wachtfogel YT, Colman RW, Eerenberg AJ, Dors D, Strack van Schijndel RJ, Thijs LG, Hack CE: Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 119:159-168, 1992
47. DeLa Cadena RA, Majluf-Cruz A, Stadnicki A, Agosti JM, Colman RW, Suffredini AF: Activation of the contact and fibrinolylic systems after intravenous administration of endotoxin to normal human volunteers: Correlation with the cytokine profile. Immunopharmacology 33:231-237, 1996
48. Adeyemi EO, Neumann S, Chadwick VS, Hodgson HJ, Pepys MB: Circulating human leucocyte elastase in patients with inflammatory bowel disease. Gut 26:1306-1311, 1985
49. Adeyemi EO, Hodgson HJ: Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 27:139-142, 1992
50. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ: Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36:897-901, 1995
51. van Dullemen HM, Van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J: Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129-135, 1995
52. Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, Rickles FR: Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 92:329-337, 1987
53. Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE: Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 3:773-778, 1992
54. Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, Rene E: Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 98:811-818, 1990
55. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzalez D, Fontcuberta J: Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 40:1883-1889, 1995
56. Holt JC, Yan ZQ, Lu WQ, Stewart GJ, Niewiarowski S: Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: A proteolytic degradation product of platelet basic protein. Proc Soc Exp Biol Med 199:171-177, 1992
57. Cohen AB, Stevens MD, Miller EJ, Atkinson MA, Mullenbach G: Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets. Am J Physiol 263:L249-L256, 1992
58. Hack CE, Ogilvie AC, Eisele B, Eerenberg AJ, Wagstaff J, Thijs LG: C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 19 Suppl 1:S19-S28, 1993